Table of Contents
To view the fulltext, log-in or choose pay-per-view options:
Get Access

Colorectal Cancer Screening: Practice Guidelines

Lieberman D.
Division of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oreg., USA Dig Dis 2012;30(suppl 2):34–38 (DOI:10.1159/000341891)

Abstract

Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.

 

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50